Clinical significance of stanniocalcin-1 detected in peripheral blood and bone marrow of esophageal squamous cell carcinoma patients

Journal of Experimental and Clinical Cancer Research

Volumn 31, Issue 1, 2012, Pages

  Song, Haizhu ^a   Xu, Biao ^a   Yi, Jun ^a  

^a JINLING HOSPITAL   (China)

Author keywords

Bone marrow; Disseminated tumor cells; Esophageal squamous cell carcinoma; Micrometastasis; Peripheral blood; Prognosis; Stanniocalcin 1

Indexed keywords

HYPOCALCIN; MESSENGER RNA; STANNIOCALCIN 1; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BONE MARROW; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; CANCER TISSUE; CELL DIFFERENTIATION; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS; ESOPHAGUS DISEASE; ESOPHAGUS RESECTION; FEMALE; GENE EXPRESSION; GENE FREQUENCY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROPORTIONAL HAZARDS MODEL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; BONE MARROW; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 84862210356     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-31-35     Document Type: Article

References (36)

1. Northwestern China: a place to learn more on oesophageal cancer. Part one: behavioural and environmental risk factors. Zheng S, Vuitton L, Sheyhidin I, Vuitton DA, Zhang Y, Lu X, Eur J Gastroenterol Hepatol 2010 22 917 925 10.1097/MEG.0b013e3283313d8b 20520561
2. Current treatment approach to locally advanced esophageal cancer: is resection mandatory? Lordick F, Ebert M, Stein HJ, Future Oncol 2006 2 717 721 10.2217/14796694.2.6.717 17155898 (Pubitemid 44941989)
3. Review: biological relevance of disseminated tumor cells in cancer patients. Riethdorf S, Wikman H, Pantel K, Int J Cancer 2008 123 1991 2006 10.1002/ijc.23825 18712708
4. Disseminated and circulating tumor cells: role in effective cancer management. Lin H, Balic M, Zheng S, Datar R, Cote RJ, Crit Rev Oncol Hematol 2011 77 1 11 10.1016/j.critrevonc.2010.04.008 20570170
5. Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance. Sun YF, Yang XR, Zhou J, Qiu SJ, Fan J, Xu Y, J Cancer Res Clin Oncol 2011 137 1151 1173 10.1007/s00432-011-0988-y 21681690
6. Stanniocalcin-1 (STC-1) as a molecular marker for human cancer. Koide Y, Sasaki T, Rinsho Byori 2006 54 213 220 16637567
7. Clinical significance of STC1 gene expression in patients with colorectal cancer. Tamura S, Oshima T, Yoshihara K, Kanazawa A, Yamada T, Inagaki D, Sato T, Yamamoto N, Shiozawa M, Morinaga S, Akaike M, Kunisaki C, Tanaka K, Masuda M, Imada T, Anticancer Res 2011 31 325 329 21273618
8. Assessment of stanniocalcin-1 as a prognostic marker in human esophageal squamous cell carcinoma. Shirakawa M, Fujiwara Y, Sugita Y, Moon JH, Takiguchi S, Nakajim K, Miyata H, Yamasaki M, Mori M, Doki Y, Oncol Rep 2012 27 940 946 22200953
9. 7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction. Rice TW, Blackstone EH, Rusch VW, Ann Surg Oncol 2010 17 1721 1724 10.1245/s10434-010-1024-1 20369299
10. Downregulation of fibulin-3 gene by promoter methylation in colorectal cancer predicts adverse prognosis. Tong JD, Jiao NL, Wang YX, Zhang YW, Han F, Neoplasma 2011 58 441 448 10.4149/neo-2011-05-441 21744999
11. Stanniocalcin-1 as a novel marker to detect minimal residual disease of human leukemia. Tohmiya Y, Koide Y, Fujimaki S, Harigae H, Funato T, Kaku M, Ishii T, Munakata Y, Kameoka J, Sasaki T, Tohoku J Exp Med 2004 204 125 133 10.1620/tjem.204.125 15383693 (Pubitemid 39335051)
12. Circulating tumor cells in perioperative esophageal cancer patients: quantitative assay system and potential clinical utility. Liu Z, Jiang M, Zhao J, Ju H, Clin Cancer Res 2007 13 2992 2997 10.1158/1078-0432.CCR-06-2072 17505001 (Pubitemid 46849575)
13. Flow cytometric analysis of CK19 expression in the peripheral blood of breast carcinoma patients: relevance for circulating tumor cell detection. Wang L, Wang Y, Liu Y, Cheng M, Wu X, Wei H, J Exp Clin Cancer Res 2009 28 57 10.1186/1756-9966-28-57 19397830
14. CK19 mRNA expression in the bone marrow of patients with esophageal squamous cell carcinoma and its clinical significance. Zhang X, Chen SB, Chen JX, Wen J, Yang H, Xie MR, Zhang Y, Hu YZ, Lin P, Dis Esophagus 2010 23 437 443 20095997
15. Bone marrow micrometastasis detected by RT-PCR in esophageal squamous cell carcinoma. Natsugoe S, Nakashima S, Nakajo A, Matsumoto M, Okumura H, Tokuda K, Miyazono F, Kijima F, Aridome K, Ishigami S, Takao S, Aikou T, Oncol Rep 2003 10 1879 1883 14534712
16. Immunocytochemical detection of disseminated tumor cells in the bone marrow of patients with esophagea carcinoma. Thorban S, Roder JD, Nekarda H, Funk A, Siewert JR, Pantel K, J Natl Cancer Inst 1996 88 1222 1227 10.1093/jnci/88.17.1222 8780632 (Pubitemid 26302036)
17. Detection of survivin-expressing circulating cancer cells in the peripheral blood of patients with esophageal squamous cell carcinoma and its clinical significance. Cao M, Yie SM, Wu SM, Chen S, Lou B, He X, Ye SR, Xie K, Rao L, Gao E, Ye NY, Clin Exp Metastasis 2009 26 751 758 10.1007/s10585-009- 9274-7 19521785
18. Stanniocalcin in the seawater salmon: structure, function, and regulation. Wagner GF, Jaworski EM, Haddad M, Am J Physiol 1998 274 1177 R1185 9575986
19. Dynamic regulation of mouse ovarian stanniocalcin expression during gestation and lactation. Deol HK, Varghese R, Wagner GF, Dimattia GE, Endocrinology 2000 141 3412 3421 10.1210/en.141.9.3412 10965914 (Pubitemid 32269031)
20. Stanniocalcin: a molecular guard of neurons during cerebral ischemia. Zhang K, Lindsberg PJ, Tatlisumak T, Kaste M, Olsen HS, Andersson LC, Proc Natl Acad Sci USA 2000 97 3637 3642 10.1073/pnas.97.7.3637 10725397 (Pubitemid 30183355)
21. Stanniocalcin-1 acts in a negative feedback loop in the prosurvival ERK1/2 signaling pathway during oxidative stress. Nguyen A, Chang AC, Reddel RR, Oncogene 2009 28 1982 1992 10.1038/onc.2009.65 19347030
22. Stanniocalcin-1 promotes tumor angiogenesis through up-regulation of VEGF in gastric cancer cells. He LF, Wang TT, Gao QY, Zhao GF, Huang YH, Yu LK, Hou YY, J Biomed Sci 2011 18 39 10.1186/1423-0127-18-39 21672207
23. Mammalian stanniocalcins and cancer. Chang AC, Jellinek DA, Reddel RR, Endocr Relat Cancer 2003 10 359 373 10.1677/erc.0.0100359 14503913 (Pubitemid 37267555)
24. Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Okabe H, Satoh S, Kato T, Kitahara O, Yanagawa R, Yamaoka Y, Tsunoda T, Furukawa Y, Nakamura Y, Cancer Res 2001 61 2129 2137 11280777 (Pubitemid 32692038)
25. Assessment of Stanniocalcin-1 mRNA as a molecular marker for micrometastases of various human cancers. Fujiwara Y, Sugita Y, Nakamori S, Miyamoto A, Shiozaki K, Nagano H, Sakon M, Monden M, Int J Oncol 2000 16 799 804 10717250
26. Metastatic susceptibility locus, an 8p hot-spot for tumour progression disrupted in colorectal liver metastases: 13 candidate genes examined at the DNA, mRNA and protein level. Macartney-Coxson DP, Hood KA, Shi HJ, Ward T, Wiles A, OConnor R, Hall DA, Lea RA, Royds JA, Stubbs RS, Rooker S, BMC Cancer 2008 8 187 10.1186/1471-2407-8-187 18590575
27. Stanniocalcin 1 and ovarian tumorigenesis. Liu G, Yang G, Chang B, Mercado-Uribe I, Huang M, Zheng J, Bast RC, Lin SH, Liu J, J Natl Cancer Inst 2010 102 812 827 10.1093/jnci/djq127 20484106
28. Co-localization of stanniocalcin-1 ligand and receptor in human breast carcinomas. McCudden CR, Majewski A, Chakrabarti S, Wagner GF, Mol Cell Endocrinol 2004 213 167 172 10.1016/j.mce.2003.10.042 15062564 (Pubitemid 38210048)
29. Characterization of gene expression induced by RET with MEN2A or MEN2B mutation. Watanabe T, Ichihara M, Hashimoto M, Shimono K, Shimoyama Y, Nagasaka T, Murakumo Y, Murakami H, Sugiura H, Iwata H, Ishiguro N, Takahashi M, Am J Pathol 2002 161 249 256 10.1016/S0002-9440(10)64176-4 12107109 (Pubitemid 34760790)
30. The diagnostic value of circulating stanniocalcin-1 mRNA in non-small cell lung cancer. Du YZ, Gu XH, Li L, Gao F, J Surg Oncol 2011 104 836 840 10.1002/jso.21948 21656524
31. Stanniocalcin-1 detection of peripheral blood in patients with colorectal cancer. Wu PP, Wu P, Huang PL, Long QQ, Bu XD, Chin J Cancer Res 2010 22 274 279 10.1007/s11670-010-0274-6
32. Detection of circulating tumor cells in early-stage breast cancer metastasis to axillary lymph nodes. Nakagawa T, Martinez SR, Goto Y, Koyanagi K, Kitago M, Shingai T, Elashoff DA, Ye X, Singer FR, Giuliano AE, Hoon DS, Clin Cancer Res 2007 13 4105 4110 10.1158/1078-0432.CCR-07-0419 17634536 (Pubitemid 47105972)
33. Stanniocalcin-1: a novel molecular blood and bone marrow marker for human breast cancer. Wascher RA, Huynh KT, Giuliano AE, Hansen NM, Singer FR, Elashoff D, Hoon DS, Clin Cancer Res 2003 9 1427 1435 12684415 (Pubitemid 36418397)
34. Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells. Fehm T, Hoffmann O, Aktas B, Becker S, Solomayer EF, Wallwiener D, Kimmig R, Kasimir-Bauer S, Breast Cancer Res 2009 11 59 10.1186/bcr2349 19664291
35. Long-term outcome of 2920 patients with cancers of the esophagus and esophagogastric junction: evaluation of the New Union Internationale Contre le Cancer/American Joint Cancer Committee staging system. Gertler R, Stein HJ, Langer R, Nettelmann M, Schuster T, Hoefler H, Siewert JR, Feith M, Ann Surg 2011 253 689 698 10.1097/SLA.0b013e31821111b5 21475008
36. Long-term survivors of esophageal carcinoma with distant lymph node metastasis. Okamura S, Fujiwara H, Shiozaki A, Komatsu S, Ichikawa D, Okamoto K, Murayama Y, Ikoma H, Kuriu Y, Nakanishi M, Ochiai T, Kokuba Y, Sonoyama T, Otsuji E, Hepatogastroenterology 2011 58 421 425 21661407